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Abstract
Background: Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection is a major source of
morbidity and mortality globally. The World Health Organization (WHO) has recommended that HIV counselling
and testing be offered routinely to TB patients in order to increase access to HIV care packages. We assessed the
uptake of provider-initiated testing and counselling (PITC), antiretroviral (ART) and co-trimoxazole preventive
therapies (CPT) among TB patients in the Northwest Region, Cameroon.
Methods: A retrospective cohort study using TB registers in 4 TB/HIV treatment centres (1 public and 3 faith-
based) for patients diagnosed with TB between January 2006 and December 2007 to identify predictors of the
outcomes; HIV testing/serostatus, ART and CPT enrolment and factors that influenced their enrolment between
public and faith-based hospitals.
Results: A total of 2270 TB patients were registered and offered pre-HIV test counselling; 2150 (94.7%) accepted
the offer of a test. The rate of acceptance was significantly higher among patients in the public hospital compared
to those in the faith-based hospitals (crude OR 1.97; 95% CI 1.33 - 2.92) and (adjusted OR 1.92; 95% CI 1.24 - 2.97).
HIV prevalence was 68.5% (1473/2150). Independent predictors of HIV-seropositivity emerged as: females, age
groups 15-29, 30-44 and 45-59 years, rural residence, previously treated TB and smear-negative pulmonary TB. ART
uptake was 50.3% (614/1220) with 17.2% (253/1473) of missing records. Independent predictors of ART uptake
were: previously treated TB and extra pulmonary TB. Finally, CPT uptake was 47.0% (524/1114) with 24% (590/1114)
of missing records. Independent predictors of CPT uptake were: faith-based hospitals and female sex.
Conclusion: PITC services are apparently well integrated into the TB programme as demonstrated by the high
testing rate. The main challenges include improving access to ART and CPT among TB patients and proper
reporting and monitoring of programme activities.
Background
Globally, tuberculosis (TB) morbidity and mortality is
partly attributed to the co-infection with human immu-
nodeficiency virus (HIV). In 2007, there were an esti-
mated 13.7 million prevalent TB cases and 9.27 million
new cases out of which 4.1 million (44%) were smear-
positive cases. Africa accounted for 31% of the new TB
cases [1]. Similarly, 33.2 million HIV prevalent and 2.5
million incident cases were recorded worldwide in 2007.
Sub-Saharan Africa alone accounted for 22.5 million of
the prevalent cases and 1.7 million of the incident cases
[2]. Among the 9.27 million incident TB cases, 1.37 mil-
lion (14.8%) were HIV-positive and Africa accounted for
79% of these cases. There were an estimated 1.32 mil-
lion deaths from HIV-negative TB patients and 456 000
TB deaths among HIV-positive patients. Deaths from
co-infected patients accounted for 23% of the estimated
2 million HIV deaths [1].
The increasing co-infection prompted the World
Health Organization (WHO) to launch the “ProTEST”
initiative as a strategy to reduce the burden of HIV-
related TB requiring collaboration between HIV and TB
programmes [3]. It promoted voluntary counselling and
testing as an entry point to access a range of TB/HIV
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with high HIV prevalence. HIV counselling and testing
has since been recommended routinely to all TB
patients [4].
Currently, the concept of provider-initiated HIV test-
ing and counselling (PITC) (which refers to HIV coun-
selling and testing recommended by health care
providers to people attending health facilities as a stan-
dard component of medical care) has been advocated.
This presents an opportunity to ensure that HIV is
more systematically diagnosed in health care services in
order to facilitate patient access to needed HIV preven-
tion, treatment, care and support services [5]. Through
this strategy, TB treatment centres have been shown to
serve as important fora for identifying patients with HIV
infection [6-8] and uptake of HIV testing among TB
patients has been impressive. Between 2002 and 2007,
testing for HIV increased from 21 806 (0.5%) to 1 mil-
lion (16%) among the notified TB cases globally. In
Africa, 491 755 TB patients were tested for HIV in 2007
and this represented 36% of all notified cases compared
to 22% in 2006. Meanwhile enrolment on antiretroviral
therapy (ART) and cotrimoxazole preventive therapy
(CPT) has also been growing steadily in absolute terms.
In 2007, 90 000 TB patients were on ART and 200 000
were on CPT. However, this has been accompanied by a
fall in the percentage of TB patients whom are diag-
n o s e dw i t hH I Va n dw h o ma r ee n r o l l e do nA R Ta n d
CPT (from 40% in 2006 to 34% in 2007 and 77% to 63%
respectively). In Africa, enrolment reached 33% for ART
and 66% for CPT [1].
In Cameroon, the National AIDS Control Committee
was created in 1986 and later, in 1987, the National
AIDS Control Programme (NACP) was launched. The
national response to HIV/AIDS has received political
support and since 1999 the fight against HIV/AIDS is
one of the national priorities. The Government drafted
the first National Strategic Plan against AIDS for 2000-
2005 which aimed essentially to prevent new infections
by promoting voluntary counselling, treating infected
persons and reducing the cost of treatment, promoting
research and preventing mother-to-child transmission of
HIV. The second plan for 2006-2010 is multi-sector
based, decentralized and involves the civil society, pri-
vate sector and grass-root communities. The second
plan comprises 6 strategic axes: universal access to HIV
prevention, universal access to treatment and care
among children and adults living with HIV/AIDS, pro-
tection and assistance to orphans and vulnerable chil-
dren, involving actors in the fight against HIV/AIDS,
epidemiological surveillance, promoting research and
reinforcing coordination, partnership, monitoring/eva-
luation [9]. The national HIV-seroprevalence was 5.4%
in 2004 [10] and there are 95 sites providing ART
treatment nationwide. Since May 2007, ART and CPT
have been provided free of charge to those eligible. At
the end December 2008, there were 153 185 HIV
patients eligible for ART (88 678 females [57.9%] and 64
506 males [42.1%]). A total of 59 960 (39.1%) of these
patients were enrolled on ART (40 357 females [67.3%]
and 19 603 males [32.7%]) [9].
The National TB Control Programme (NTCP) was
launched in 1996 and, in 2002, it was recognized as a
priority programme by the Ministry of Public Health.
The NTCP is organized according to three levels of
intervention: central, regional and peripheral. The Min-
istry of Public Health is responsible for the organization
and implementation of the programme at the central
level and provides the annual budget and permanent
financial support. The central level comprises the
National Tuberculosis Control Committee (which
defines the general objectives of the programme), the
Consultative Scientific Committee, the Central Techni-
cal Group (which is the executive organ), the Tubercu-
losis National Reference Laboratory and the Chest
Service of the Jamot Hospital (which is a third referral
level in matters of TB control in the country). The
regional level is under the authority of the Regional
Delegate of Public Health and has as its mission the
organization, coordination, follow-up and evaluation of
the fight against TB in the region. The peripheral level
comprises the health districts that make up the structure
on which the TB programme is built and participates in
TB case finding and treatment, as well as the keeping of
the TB register. The specific objectives of the NTCP are
to cure at least 85% of detected cases of sputum-smear
positive pulmonary TB (PTB), to detect 70% of existing
cases of sputum-smear positive PTB patients, and to
protect through BCG vaccination at least 80% of chil-
dren born each year [11].
The country is implementing the Directly Observed
Treatment, Short-Course (DOTS) strategy with 100%
coverage [1]. There are 217 TB diagnostic and treatment
centres in 142 health districts nationwide. The case
detection rate from DOTS services in 2007 for all new
cases was 65% and 91% for new smear-positive cases
[1]. The case notification rate has been increasing stea-
dily since 2000 from 33/100 000 population/year to 130
in 2007. A total of 36 088 prevalent and 35 556 incident
TB cases were recorded in 2007. Among the 2006
cohort (13 811 patients) of smear-positive patients, a
64% cure rate was recorded with a 74% treatment suc-
cess rate, 6% death rate and 13% default rate [1]. Colla-
boration with the AIDS Control Programme began in
2004 and HIV counselling and testing are now routine
and have been free for all TB patients since 2006. Since
2006, the number of TB patients tested for HIV has
increased from 8 637 to 11 825 in 2007 and to 16 144
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43.8% and 40.4% respectively in the adult population [9].
In 2004, the Northwest Region (NWR), one of the 10
regions in the country, had the highest HIV-seropreva-
lence of 8.7% (11.9% amongst females compared to 5.2%
amongst males [10]) and HIV-related TB still remains a
public health priority in the region. Since 1990, when
multi-party politics was introduced in the country, there
have been several anti-government demonstrations espe-
cially in the NWR which is the stronghold of the major
opposition party in the country: the social democratic
front (SDF). This has led to riots and civil unrest with
frequent clashes between law enforcement officials and
the public with several reported incidences of sexual
harassment and rape which could account partly for the
high HIV prevalence in the region.
Although TB/HIV collaborative activities began in
2004, programmatic changes involved re-designing TB
registers to capture uptake of HIV testing, ART and
CPT services. These registers went operational in all
TB diagnostic and treatment centres in January 2006.
The staffs in the centres were also trained in TB diag-
nosis and treatment, as well as record keeping and
reporting. This study assessed the uptake of PITC,
ART and CPT services and also factors that influenced
their uptake among TB patients in selected treatment
facilities within the NWR between January 2006 and
December 2007 when TB/HIV collaborative activities
became operational.
Methods
Study setting
Cameroon’s population is approximately 18.4 million
with an estimated land area of 475 440 km
2.T h e r ea r e
10 regions and this study was carried out in the NWR,
which has a population of over 1.8 million and is com-
prised of 7 divisions; the capital, Bamenda, has an urban
population of over 300 000. There are 13 health districts
with 1 regional hospital, 19 district hospitals, and 106
assimilated district hospitals and health centres [10]. In
addition, there are private and faith-based hospitals with
primary health centres.
Four hospitals out of 10 providing comprehensive TB/
HIV treatment and support services in the NWR were
purposively selected because of: i) their accessibility; ii)
patient load; iii) diversity of patients since they serve
both rural and urban populations; iv) similarity in the
services provided since they act as referral centres in the
region; and v) possibility to evaluate the services
between public and faith-based settings because of per-
ceived differences amongst the population with regards
to the quality of patient care, user friendliness and cost
in accessing treatment. These included 1 public hospital
(Bamenda Regional Hospital) and 3 faith-based
hospitals: Banso Baptist Hospital, Mbingo Baptist Hospi-
tal, and Njinikom Catholic Hospital.
Tuberculosis services
TB diagnosis, treatment, follow-up and documentation
in these facilities are intended to follow the national
guidelines [11]. Diagnosis is by sputum microscopy
which costs 1000 FCFA (2.4 US$) during the entire TB
treatment. Patients with at least 1 sputum smear posi-
tive for acid-fast bacilli are classified smear-positive
PTB. In cases with negative smears, diagnosis is made
clinically and/or by chest x-ray findings consistent with
PTB since sputum culture is not routinely performed
because of cost and inadequate human resources. Diag-
nosis of extra-pulmonary TB (EPTB) is based on clinical
and/or radiological findings, biopsies and laboratory
examination of aspirates from affected areas.
Anti-TB drugs have been provided free of charge since
2004 and treatment of newly diagnosed PTB/EPTB lasts
6 months, comprising an initial 2-month intensive phase
with a fixed dose combination of Rifampicin, Isoniazid,
Pyrazinamide and Ethambutol with an initial 2 weeks of
hospitalisation; this is followed by a 4-month continuous
phase of daily Rifampicin and Isoniazid. Diagnosis and
treatment are made by trained medical officers but fol-
low-up and documentation are performed by trained
nurses.
Counselling services
All diagnosed TB cases are counselled for HIV by
trained counsellors within the TB unit using the ‘opt-
out’ approach, where patients reserve the right to accept
or refuse testing for HIV without reprisal from provi-
ders. Post-test counselling is offered to all who accept
testing regardless of the outcome, support services to
HIV-positive cases like the chaplaincy department and
HIV support groups are also made available. Based on
the national treatment guidelines, ART is initiated in
the following scenarios: i) if the CD4-count is <200
cells/mm
3 between 2-8 weeks after commencing anti-
TB treatment; ii) if the CD4-count is between 200-350
cells/mm
3 after 8 weeks of anti-TB treatment; iii) if the
CD4-count is above 350 cells/mm
3, ART is differed and
the patient is re-evaluated after 8 weeks and at the end
of anti-TB treatment; and iv) in the absence of CD4-
count, if the total lymphocyte count is <1200 cells/mm
3,
ART is introduced between 2-8 weeks of anti-TB treat-
ment [12].
Data sources and analysis
Data were obtained from TB treatment registers in the
study hospitals for patients diagnosed between January
2006 and December 2007. Register data in the treatment
centres are collated and forwarded to the Ministry of
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profile and HIV services were obtained. HIV treatment
registers were also reviewed for information on ART for
cases not documented in TB registers.
Data were entered using Microsoft Excel™ and ana-
lyzed using Epi Info™ version 3.4.3. Descriptive statistics
of patients were performed and main outcome variables
(HIV testing and status, ART and CPT uptake) were
dichotomized and potential factors associated with the
outcomes were tested individually by univariate analysis.
Logistic regression analysis was performed having con-
trolled for other variables to identify independent pre-
dictors using odds ratio (OR), 95% confidence interval
(95% CI) and p-values less than 0.05 were considered
statistically significant.
Ethical approval
Ethical approval for the study was obtained from the
Delegation of Public Health for the NWR (N° 401/
NWP/PDPH/08), Internal Review Board of the Regional
Hospital, Bamenda and, the Cameroon Baptist Conven-
tion Health Board Institutional Review Board (IRB
2007-09). Informed consent was also obtained from the
Regional coordinator of TB and TB coordinators/nurses
in the study hospitals. They were assured that all infor-
mation in the TB/HIV registers would be treated with
strict confidentiality. During data entry, only the
patients’ serial numbers in the records were collected to
ensure anonymity and the data was password-protected.
Results
Patient Characteristics
A total of 2270 TB patients were treated between January
2006 and December 2007. The mean age of the patients
was 34 years (range 1 month - 88 years). The detailed
patients’ characteristics are presented in Table 1.
HIV Testing
All 2270 patients were offered pre-HIV test counselling
and the outcomes are presented in Figure 1. In the
Table 1 TB patients’ characteristics by study hospitals 2006-2007 (n = 2270)
Variable ALL BBH† MBH BRH NJH
n (%) 468 (20.6) 564 (24.8) 1063 (46.8) 175 (7.7)
Sex
Male 1163 (51.2) 255 (54.5) 315 (55.9) 509 (47.9) 84 (48.0)
Female 1107 (48.8) 213 (45.5) 249 (44.1) 554 (52.1) 91 (52.0)
Age Group (years)
0-14 98 (4.3) 20 (4.3) 29 (5.1) 44 (4.1) 5 (2.9)
15-29 772 (34.0) 164 (35.0) 197 (34.9) 343 (32.3) 68 (38.9)
30-44 971 (42.8) 193 (41.2) 232 (41.1) 464 (43.7) 82 (46.9)
45-59 308 (13.6) 61 (13.0) 75 (13.3) 158 (14.9) 14 (8.0)
≥ 60 121 (5.3) 30 (6.4) 31 (5.5) 54 (5.1) 6 (3.4)
Residence
Rural 1180 (52.0) 404 (86.3) 302 (53.5) 323 (30.4) 151 (86.3)
Urban 1090 (48.0) 64 (13.7) 262 (46.5) 740 (69.6) 24 (13.7)
TB Type
SPPTB 1369 (60.3) 361 (77.1) 330 (58.5) 582 (54.8) 96 (54.9)
SNPTB 534 (23.5) 38 (8.1) 130 (23.0) 290 (27.3) 76 (43.4)
EPTB 367 (16.2) 69 (14.7) 104 (18.4) 191 (18.0) 3 (1.7)
TB Category
New 2081 (91.7) 458 (97.9) 543 (96.3) 920 (86.5) 160 (91.4)
Others* 189 (8.3) 10 (2.1) 21 (3.7) 143 (13.5) 15 (8.6)
Treatment Outcome
Treatment Success
¶ 1602 (70.6) 354 (75.7) 385 (68.2) 751 (70.7) 112 (64.0)
Cured 855 (37.7) 240 (51.3) 161 (28.5) 406 (38.2) 48 (27.4)
Completed treatment 747 (32.9) 114 (24.4) 224 (39.7) 345 (32.5) 64 (36.6)
Died 297 (13.1) 70 (15.0) 60 (10.6) 136 (12.8) 31 (17.7)
Treatment failure 13 (0.6) 5 (1.1) 5 (0.9) 3 (0.3) 0 (0)
Treatment default 111 (4.9) 21 (4.5) 31 (5.5) 40 (3.8) 19 (10.9)
Transferred out 247 (10.9) 18 (3.8) 83 (14.7) 133 (12.5) 13 (7.4)
† BBH (Banso Baptist Hospital), MBH (Mbingo Baptist Hospital), BRH (Bamenda Regional Hospital), NJH (Njinikom Hospital)
*Others - Includes treatment failure, treatment default, transferred in from another facility and relapse cases
¶ Treatment Success = Cured + Completed treatment
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compared to 93.2% (1125/1207) in faith-based hospitals.
Among all the variables considered, testing was signifi-
cant only in the public hospital compared to the faith-
based hospitals (crude OR 1.97; 95% CI 1.33 - 2.92) and
(adjusted OR 1.92; 95% CI 1.24 - 2.97) (Data not
shown).
HIV Seroprevalence
A total of 2150 patients were tested for HIV and the
outcomes are presented in Figure 1. In the public hospi-
tal, 76.0% (779/1025) of patients tested positive com-
pared to 61.7% (694/1125) in the faith-based hospitals.
Patients in the public hospital were more likely to be
HIV-positive compared to those in faith-based hospitals
(crude OR 1.97; 95% CI 1.63 - 2.37) and (adjusted OR
2.08; 95% CI 1.66 - 2.61). Females, age groups 15-29,
30-44 and 45-59 years, patients from rural areas, pre-
viously treated TB and SNPTB emerged as independent
predictors of HIV-seropositivity in multivariate analysis
(Table 2).
Antiretroviral Therapy Uptake
Records on ART were available for 1220 of 1473 HIV-
positive TB patients and 50.3% (614) were enrolled on
ART; 52.9% (408/771) in the public and 45.9% (206/449)
in faith-based hospitals). Enrolment was significantly
higher in the public hospital compared to the faith-
based hospitals in univariate analysis (crude OR 1.33;
95% CI 1.05 - 1.67). Previously treated TB and EPTB
emerged as independent predictors of ART enrolment
in multivariate analysis (Table 3).
Co-trimoxazole Preventive Therapy Uptake
Records on CPT were available for 1114 of 1473 HIV-
positive patients and 47.0% (524) were enrolled on CPT:
35.2% (241/684) in the public hospital and 65.8% (283/
430) in the faith-based hospitals. Enrolment was signifi-
c a n t l yl o w e ri nt h ep u b l i ch o s p i t a lc o m p a r e dt ot h e
faith-based hospitals (crude OR 0.28; 95% CI 0.22 -
0.36) and (adjusted OR 0.29; 95% CI 0.22 - 0.38). Female
sex also emerged as an independent predictor of CPT
enrolment in multivariate analysis (Table 4).
Discussion
Our study revealed that overall uptake of PITC among
TB patients in the region is high (94.7%). This high test-
ing rate might be attributed to the fact that HIV/AIDS
is now seen as a “normal” disease for which there is
free, life-saving treatment available. It might also be due
to the influence of healthcare providers, since it is rare
for patients to object to decisions from health authori-
ties. High testing rates have also been reported in other
studies in Africa [13-15]. Testing rates were slightly
higher in the public hospital compared to the faith-
based hospitals but other variables assessed in the study
showed no significant associations with testing rates.
Further research is needed to identify the reasons for
the underlying structural differences in testing between
treatment facilities and to evaluate the impact of other
socio-economic factors on testing which we were unable
to assess because they have not been documented routi-
nely in TB registers.
The study demonstrated a 68.5% HIV prevalence
among TB patients, similar to other studies in Africa
[14-16] but higher than the national figures for 2006
(38.9%) and 2007 (43.8%) [9]. These discrepancies could
be attributed to the high HIV prevalence in the NWR
and because of improved monitoring and reporting ser-
vices compared to the pre-TB/HIV collaborative era.
HIV-seroprevalence was higher among females, 73.1%
(773/1057) consistent with results of the 2004 country
Demographic Health survey [10] and findings in other
studies [15-17]. The 15-59 years age group, which is the
productive population, was the group most affected by
the epidemic. One of the strategies of the NACP is to
provide universal access to HIV prevention as evidenced
by the numerous HIV sensitization and prevention cam-
paigns nationwide. However, future efforts should speci-
fically address the needs of the adult population,
especially females and the rural communities who are
particularly disadvantaged socio-economically and thus
more vulnerable to the infection.
Our study revealed a 50% (614/1220) uptake of ART
among TB patients who had their HIV treatment history
documented (82.8%). Assuming all co-infected patients
are eligible for ART in the absence of CD4-count [18],
Figure 1 A schematic representation of HIV diagnostic
processes and outcomes among TB patients.
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would be 41.7% (614/1473). These figures are relatively
higher than findings in Malawian studies (13% and 16%)
[19,20]. Plausible explanations for the findings in our
study could be the scale-up and decentralisation of ART
services in the country [21], increasing awareness of the
benefits of ART which has encouraged testing for HIV,
reduction in the cost of the CD4-count test to increase
ART eligibility, and training/increasing the number of
HIV treatment officers within the facilities. Despite the
relatively high uptake of ART in the region compared to
other studies, our study revealed lapses in data report-
ing. Seventeen percent (253/1473) of ART data were not
documented in the registers, which reflects the opera-
tional challenges in establishing mechanisms for, and
implementing, a sound monitoring, reporting, and eva-
luation of programme activities; this calls for a rigorous
reporting system, an issue which could be addressed
with the use of electronic medical records (EMR).
Despite its challenges (which include setting up and
maintaining the system, training of local staff in data
entry and management and ensuring a stable power
supply to minimise data loss) EMR have been used suc-
cessfully to support HIV/TB treatment in resource-lim-
ited settings [22,23], improving not only patient and
programme monitoring, reporting and evaluation, but
also management of drug supplies. However, any con-
sideration of such systems will have to reflect the local
constraints and adapt to the local needs. Our study also
revealed that previously treated TB patients were more
Table 2 Logistic regression analysis of HIV status with respect to potential predictors
Variable HIV Positive
# Univariate Analysis Multivariate Analysis
N (%) OR
a 95% CI
b P-value OR
c 95% CI P-value
All 1473 (68.5)
Health Facility
Faith-based 694 (61.7) 1 - - 1 - -
Public 779 (76.0) 1.97 (1.63 - 2.37) 0.000 2.08 (1.66 - 2.61) 0.000
d
Sex
Male 700 (64.0) 1 - - 1 - -
Female 773 (73.1) 1.53 (1.27 - 1.84) 0.000 1.78 (1.45 - 2.19) 0.000
Age Group
0-14 44 (48.4) 1 - - 1 - -
15-29 428 (58.5) 1.51 (0.98 - 2.34) 0.065 2.16 (1.33 - 3.50) 0.002
30-44 754 (81.3) 4.66 (2.99 - 7.25) 0.000 7.28 (4.47 - 11.87) 0.000
45-59 208 (72.0) 2.74 (1.69 - 4.45) 0.000 3.90 (2.31 - 6.60) 0.000
≥ 60 39 (34.8) 0.57 (0.32 - 1.00) 0.052 0.70 (0.38 - 1.28) 0.249
Residence
Rural 756 (68.0) 1 - - 1 - -
Urban 717 (69.0) 1.05 (0.87 - 1.25) 0.631 0.72 (0.58 - 0.89) 0.003
Category of Patients
Others* 143 (79.0) 1 - - 1 - -
New 1330 (67.5) 0.55 (0.38 - 0.80) 0.002 0.58 (0.39 - 0.87) 0.008
TB Type
EPTB 206 (60.2) 1 - - 1 - -
SNPTB 417 (81.3) 2.87 (2.10 - 3.91) 0.000 3.03 (2.16 - 4.25) 0.000
SPPTB 850 (65.6) 1.26 (0.99 - 1.61) 0.064 1.13 (0.86 - 1.49) 0.387
a- crude odds ratio
b- 95% confidence interval
c- adjusted odds ratio
d- significant values are highlighted
*Others - Includes treatment failure, treatment default, transferred in from another facility and relapse cases
# Denominator is the total number of patients tested for HIV (2150)
Njozing et al. BMC Public Health 2010, 10:129
http://www.biomedcentral.com/1471-2458/10/129
Page 6 of 10likely to be on ART compared to newly diagnosed TB
patients. Recently, the SAPIT study in South Africa [24]
showed that mortality among TB/HIV co-infected
patients can be reduced by 55% if ART is provided con-
comitantly with TB treatment. Therefore, to ensure a
s u s t a i n e ds c a l e - u po fA R Ta n dr e d u c em o r b i d i t ya n d
mortality associated with the co-infection, concomitant
treatment with ART should be a priority. However, this
should be guided by their CD4-count result which
u n d e r l i n e st h en e e df o rap roper monitoring system.
Moreover, making CD4-count tests free of charge would
increase eligibility and improve ART uptake in the long
run.
We also demonstrated a low uptake of CPT (47.0%)
among co-infected patients with 24% (359/1473) of CPT
records missing. Assuming all HIV-positive patients are
eligible for CPT, then 36% (524/1473) of the TB
patients were on CPT. Although uptake was better in
the faith-based hospitals (65.8%) compared to the public
hospital (35.2%), these figures are lower than results
from studies in Malawi with uptakes above 90% [13,15].
Considering the fact that CPT is a simple intervention
with less stringent eligibility criteria compared to ART,
a higher uptake compared to ART could have reason-
ably been expected. The habit of clinicians tending to
place more emphasis on ART since it is regarded as
life-saving while neglecting CPT might be an explana-
tion for this finding. Besides, probably due to multitask-
ing in treatment centres, there might also be a tendency
for staff to neglect documenting CPT activities.
Table 3 Logistic regression analysis of ART uptake with respect to potential predictors
Variable ART
# Univariate Analysis Multivariate Analysis
N (%) OR
a 95% CI
b P-value OR
c 95% CI P-value
All 614 (50.3)
Health Facility
Faith-based 206 (45.9) 1 - - 1 - -
Public 408 (52.9) 1.33 (1.05 - 1.67) 0.018 1.13 (0.87 - 1.46) 0.371
Sex
Male 281 (49.6) 1 - - 1 - -
Female 333 (51.0) 1.06 (0.85 - 1.33) 0.617 1.12 (0.88 - 1.42) 0.356
Age Group
0-14 17 (44.7) 1 - - 1 - -
15-29 156 (44.7) 1.00 (0.51 - 1.96) 0.997 1.26 (0.63 - 2.53) 0.513
30-44 322 (52.1) 1.34 (0.70 - 2.60) 0.379 1.64 (0.84 - 3.22) 0.149
45-59 101 (56.4) 1.60 (0.79 - 3.25) 0.191 1.93 (0.95 - 3.95) 0.071
≥ 60 18 (50.0) 1.24 (0.50 - 3.08) 0.651 1.32 (0.52 - 3.32) 0.559
Residence
Rural 270 (46.6) 1 - - 1 - -
Urban 344 (53.8) 1.33 (1.07 - 1.67) 0.012 1.20 (0.94 - 1.54) 0.144
Category of Patients
Others* 75 (57.7) 1 - - 1 - -
New 539 (49.4) 0.72 (0.52 - 1.04) 0.077 0.63 (0.43 - 0.93) 0.019
d
TB Type
EPTB 107 (56.0) 1 - - 1 - -
SNPTB 212 (55.6) 0.98 (0.69 - 1.40) 0.931 1.02 (0.72 - 1.46) 0.899
SPPTB 295 (45.5) 0.66 (0.47 - 0.91) 0.011 0.65 (0.47 - 0.92) 0.013
a- crude odds ratio
b- 95% confidence interval
c- adjusted odds ratio
d- significant values are highlighted
*Others - Includes treatment failure, treatment default, transferred in from another facility and relapse cases
# Denominator is the total number of HIV-positive patients with ART records available (1220)
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stocks have been reported and patients have been
required to procure treatment personally and this might
be another explanation for the low enrolment. However,
it was encouraging to observe a higher CPT enrolment
among females. It is common that African women are
financially dependent on their partners and, because of
this, there is apprehension about fair access to HIV ser-
vices [20]. Studies in Africa have demonstrated that
CPT reduces morbidity and mortality in TB/HIV co-
infection [13,25,26]. It is essential for providers to be
reminded of the importance of providing these simple
but important interventions to HIV-infected patients
and to vigorously monitor and report programme activ-
ities. Further research is also required to explore the
reasons for the above finding and address the opera-
tional challenges.
Limitations in our study included the fact that the
study sites were purposively selected and the figures
o b t a i n e dm a yn o tb eat r u er e f l e c t i o no ft h ee n t i r e
region. However, our samples were accredited treatment
centres and also served as referral centres in the region
and received a diversity of patients with characteristics
similar to those in other centres. ART and CPT services
should be recorded according to the national guidelines,
but registers were not complete. Missing records in TB
registers were searched in HIV registers by either com-
paring names on TB registers or checking for patients
on Efavirenz®-based ART combinations to identify TB
patients. This may have affected the accuracy and
Table 4 Logistic regression analysis of CPT uptake with respect to potential predictors
Variable CPT
# Univariate Analysis Multivariate Analysis
N (%) OR
a 95% CI
b P-value OR
c 95% CI P-value
All 524 (47.0)
Health Facility
Faith-based 283 (65.8) 1 - - 1 - -
Public 241 (35.2) 0.28 (0.22 - 0.36) 0.000 0.29 (0.22 - 0.38) 0.000
d
Sex
Male 231 (45.0) 1 - - 1 - -
Female 293 (48.8) 1.16 (0.92 - 1.47) 0.215 1.32 (1.02 - 1.71) 0.036
Age Group
0-14 13 (35.1) 1 - - 1 - -
15-29 148 (45.7) 1.55 (0.76 - 3.16) 0.224 0.89 (0.42 - 1.90) 0.766
30-44 280 (49.4) 1.80 (0.90 - 3.61) 0.097 1.26 (0.60 - 2.60) 0.542
45-59 73 (46.5) 1.60 (0.76 - 3.38) 0.213 1.20 (0.55 - 2.61) 0.649
≥ 60 10 (34.5) 0.97 (0.35 - 2.70) 0.956 0.74 (0.26 - 2.15) 0.583
Residence
Rural 290 (54.4) 1 - - 1 - -
Urban 234 (40.3) 0.57 (0.45 - 0.72) 0.000 0.86 (0.65 - 1.12) 0.256
Category of Patients
Others* 57 (47.5) 1 - - 1 - -
New 467 (47.0) 0.98 (0.67 - 1.43) 0.915 0.77 (0.51 - 1.17) 0.223
TB Type
EPTB 74 (42.3) 1 - - 1 - -
SNPTB 145 (42.9) 1.03 (0.71 - 1.48) 0.894 0.83 (0.65 - 1.12) 0.256
SPPTB 305 (50.7) 1.41 (1.00 - 1.98) 0.049 0.83 (0.56 - 1.23) 0.350
a- crude odds ratio
b- 95% confidence interval
c- adjusted odds ratio
d- significant values are highlighted
*Others - Includes treatment failure, treatment default, transferred in from another facility and relapse cases
# Denominator is the total number of HIV-positive patients with CPT records available (1114)
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Page 8 of 10completeness of the data and underestimated the rates.
Documentation of CD4-count results was not routinely
performed and made it problematic to correctly assess
ART eligibility. It is difficult therefore to assess if the
50% ART enrolment observed was due to inaccessibility
to CD4-counts or because of a low proportion of TB
patients being eligible for ART. Besides, ART uptake is
time dependent and our model did not take this into
account; this might have also affected our results. More-
over, the predictors in our model were patient-based
and did not take into consideration the health sector
factors like supply-oriented issues that might have
affected uptake of these services. Our study assessed
uptake of HIV services in TB patients shortly after
implementation of collaborative activities; carrying out
the study during this period might potentially have dis-
torted the findings as operational challenges during the
implementation phase may well have improved over
time. Finally, it is unknown if the high uptake of PITC
was influenced or based on voluntary and informed
choices. A qualitative study to explore the counselling
services would shed more light on this.
Conclusions
Our study demonstrated that PITC services are appar-
ently well integrated into the TB programme in the
region as evidenced by the high uptake of testing. This
high uptake should translate into improved access to
ART and CPT and ensure concomitant treatment with
anti-TB drugs in those eligible for ART. Another chal-
lenge is ensuring the free availability to all TB patients
of CD4 tests, other pre-therapeutic investigations asso-
ciated with HIV care, and medical consultations; such
availability will increase ART eligibility and ensure sus-
tainability of the scale-up of HIV services. As collabora-
tive activities are strengthened nationwide, staff capacity
building in ART treatment and the importance of mana-
ging HIV opportunistic infections including the provi-
sion of CPT should be a priority. Finally, while stressing
the need for an efficient documentation of programme
activities in treatment centres, the use of EMR will,
despite its challenges, inevitably improve HIV/TB treat-
ment, as well as the reporting and monitoring of pro-
gramme activities.
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